Patent ID: 9012427
Filing Date: 2015-04-21
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition comprising an effective amount of: a compound of Formula (A), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, wherein the compound of Formula (A) has the structure: a first compound of Formula (C), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, the first compound of Formula (C) is and a second compound of Formula (C), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, the second compound of Formula (C) is selected from the group consisting of daclatasvir, PPI-461, ACH-2928, GS-5885, BMS-824393, ABT 267, ACH-3102, AZD-7295, IDX719, PPI-668, MK8742 and GSK805.